採血管市場：将来予測 (2025年～2030年)

採血管市場は、CAGR 5.75%で、2025年の35億300万米ドルから2030年には46億3,300万米ドルに成長すると予測されます。

世界の採血管市場は、慢性疾患の有病率の上昇、高齢化、外科手術の増加などを背景に、大きな成長を遂げようとしています。特に糖尿病やがんなど、頻繁な診断が必要な疾患に対する血液検査や保存のニーズが高まっていることが、市場の追い風となっています。効率や使い勝手の向上など、チューブ設計の技術的進歩が需要をさらに押し上げています。製造コストの高さや規制の複雑さといった課題にもかかわらず、市場は強固な医療インフラに支えられており、米国はその先進的な医療エコシステムと検査量の多さから、圧倒的な市場として浮上しています。

市場促進要因

糖尿病やがんなどの慢性疾患の罹患率の増加は、診断とモニタリングのための頻繁な血液検査を必要とする主な促進要因です。世界保健機関（WHO）は、120万人の小児を含む1,020万人の結核患者を世界に報告し、信頼性の高い採血システムの需要を浮き彫りにしました。また、手術件数の増加も市場の成長を後押ししており、採血管は術前・術後の検査に不可欠です。例えば、ポルトガル、デンマーク、ノルウェー、アイルランドなどの欧州諸国では手術件数が多く、効率的な採血ソリューションの必要性が強調されています。さらに、2023年1月に発売されたBDのVacutainer（R）Serum Tube with K2EDTAのような血清分離のための技術進歩は、使い勝手を向上させ、外科的陽男をサポートし、市場拡大を促進しています。WHOの2023年6月のデータでは1億1,850万本が収集されており、世界の献血の増加は、安全な保管と検査を確実にするための専用チューブの需要をさらに増幅しています。

目次

第1章 イントロダクション

• 市場概要
• 市場の定義
• 分析範囲
• 市場セグメンテーション
• 通貨
• 前提条件
• 基準年と予測年のタイムライン

第2章 分析手法

• 分析デザイン
• 分析データ
• 検証

第3章 エグゼクティブサマリー

• 主な分析結果

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
• 業界バリューチェーン分析

第5章 採血管市場の分析：製品種類別

• イントロダクション
• EDTAチューブ
• ヘパリンチューブ
• ヘパリン血漿分離チューブ
• 血清分離管
• その他

第6章 採血管市場の分析：材料別

• イントロダクション
• プラスチック
  • ポリエチレンテレフタレート
  • ポリプロピレン
  • ポリスチレン
  • その他
• ガラス

第7章 採血管市場の分析：エンドユーザー別

• イントロダクション
• 診断センター
• 病院・診療所
• 研究開発センター

第8章 採血管市場の分析：地域別

• イントロダクション
• 北米
  • 製品種類別
  • 材料の種類別
  • エンドユーザー別
  • 国別
    • 米国
    • カナダ
    • メキシコ
• 南米
  • 製品種類別
  • 材料の種類別
  • エンドユーザー別
  • 国別
    • ブラジル
    • アルゼンチン
    • その他
• 欧州
  • 製品種類別
  • 材料の種類別
  • エンドユーザー別
  • 国別
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • その他
• 中東・アフリカ
  • 製品種類別
  • 材料の種類別
  • エンドユーザー別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • その他
• アジア太平洋
  • 製品種類別
  • 材料の種類別
  • エンドユーザー別
  • 国別
    • 日本
    • 中国
    • インド
    • 韓国
    • インドネシア
    • 台湾
    • その他

第9章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場収益性
• 企業合併・買収 (M&A)、合意、事業協力
• ベンダー競争力マトリックス

第10章 企業プロファイル

• BD
• Cardinal Health
• CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
• FL MEDICAL S.r.l.
• Fresenius Kabi AG
• Greiner Bio One International GmbH
• Thermo Fisher Scientific Inc.
• Kawasumi Laboratories America
• McKesson Medical-Surgical Inc.
• QIAGEN
• SARSTEDT AG & Co. KG
• AdvaCare Pharma

The Blood Collection Tubes Market is expected to grow from USD 3.503 billion in 2025 to USD 4.633 billion in 2030, at a CAGR of 5.75%.

The global blood collection tubes market is poised for significant growth, driven by the rising prevalence of chronic diseases, an aging population, and increasing surgical procedures. The market is fueled by the growing need for blood testing and storage, particularly for conditions like diabetes and cancer, which require frequent diagnostics. Technological advancements in tube design, such as improved efficiency and user-friendliness, further propel demand. Despite challenges like high production costs and regulatory complexities, the market is supported by robust healthcare infrastructure, with the United States emerging as a dominant market due to its advanced medical ecosystem and high testing volumes.

Market Drivers

The increasing incidence of chronic diseases, such as diabetes and cancer, is a primary driver, necessitating frequent blood tests for diagnosis and monitoring. The World Health Organization reported 10.2 million tuberculosis cases globally, including 1.2 million children, highlighting the demand for reliable blood collection systems. The growing number of surgical procedures also boosts market growth, as blood collection tubes are essential for preoperative and postoperative testing. For instance, high surgical volumes in European countries like Portugal, Denmark, Norway, and Ireland underscore the need for efficient blood collection solutions. Additionally, technological advancements, such as BD's Vacutainer(R) Serum Tube with K2EDTA launched in January 2023 for serum separation, enhance usability and support surgical applications, driving market expansion. The global rise in blood donations, with 118.5 million units collected as per WHO's June 2023 data, further amplifies demand for specialized tubes to ensure safe storage and testing.

Market Segmentation

The market is segmented by application, tube type, and geography. Applications include diagnostics, surgical procedures, and blood donation, with diagnostics leading due to chronic disease prevalence. Tube types encompass serum, plasma, and EDTA tubes, tailored to specific testing needs. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The United States dominates North America, driven by its USD 3.8 trillion healthcare industry in 2022 and high surgical and diagnostic activity. The integration of microfluidics in point-of-care (POC) diagnostics, enabling portable and affordable testing, further supports market growth in the region.

Industry Analysis

Porter's Five Forces model evaluates competitive dynamics, analyzing supplier power, buyer influence, and market rivalry. An industry value chain analysis identifies key players in tube manufacturing, distribution, and healthcare integration, emphasizing their roles in ensuring quality and efficiency. The regulatory framework, including standards for medical device safety and quality, is critical for maintaining trust and compliance, particularly in high-income countries with stringent healthcare regulations.

Competitive Landscape

Key players, such as BD, focus on innovation, developing advanced tubes like the Vacutainer(R) series to meet surgical and diagnostic needs. The vendor matrix categorizes companies as leaders, followers, challengers, or niche players based on their strategies, with an emphasis on user-friendly and efficient solutions. Investments in R&D and partnerships with healthcare providers strengthen market positions.

Challenges

High production costs for advanced blood collection tubes and stringent regulatory requirements pose barriers. Ensuring consistent quality across diverse applications and addressing supply chain constraints in developing regions are additional challenges requiring strategic solutions.

The blood collection tubes market is set for robust growth, driven by chronic disease prevalence, surgical demand, and technological advancements. The U.S. leads due to its advanced healthcare infrastructure and high testing volumes, while Asia Pacific shows potential with rising healthcare needs. Continued innovation and regulatory compliance will be critical for overcoming cost and quality challenges, ensuring the market meets global diagnostic and surgical demands.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Product Type

• EDTA Tubes
• Heparin Tube
• Heparin Plasma Separating Tube
• Serum Separating Tube
• Others

By Material Type

• Plastic
• Polyethylene Terephthalate
• Polypropylene
• Polystyrene
• Others
• Glass

By End-User

• Diagnostics Centers
• Hospitals and Clinics
• R&D Centers

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Data
• 2.3. Validation

3. EXECUTIVE SUMMARY

• 3.1. Key Findings

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. EDTA Tubes
• 5.3. Heparin Tube
• 5.4. Heparin Plasma Separating Tube
• 5.5. Serum Separating Tube
• 5.6. Others

6. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY MATERIAL TYPE

• 6.1. Introduction
• 6.2. Plastic
  • 6.2.1. Polyethylene Terephthalate
  • 6.2.2. Polypropylene
  • 6.2.3. Polystyrene
  • 6.2.4. Others
• 6.3. Glass

7. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY END-USER

• 7.1. Introduction
• 7.2. Diagnostics Centers
• 7.3. Hospitals and Clinics
• 7.4. R&D Centers

8. BLOOD COLLECTION TUBES MARKET ANALYSIS, BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Product Type
  • 8.2.2. By Material Type
  • 8.2.3. By End-Users
  • 8.2.4. By Country
    • 8.2.4.1. United States
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Product Type
  • 8.3.2. By Material Type
  • 8.3.3. By End-Users
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Product Type
  • 8.4.2. By Material Type
  • 8.4.3. By End-Users
  • 8.4.4. By Country
    • 8.4.4.1. UK
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Product Type
  • 8.5.2. By Material Type
  • 8.5.3. By End-Users
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. United Arab Emirates
    • 8.5.4.3. Israel
    • 8.5.4.4. Others
• 8.6. Asia Pacific
  • 8.6.1. By Product Type
  • 8.6.2. By Material Type
  • 8.6.3. By End-Users
  • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Indonesia
    • 8.6.4.6. Taiwan
    • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. BD
• 10.2. Cardinal Health
• 10.3. CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
• 10.4. FL MEDICAL S.r.l.
• 10.5. Fresenius Kabi AG
• 10.6. Greiner Bio One International GmbH
• 10.7. Thermo Fisher Scientific Inc.
• 10.8. Kawasumi Laboratories America
• 10.9. McKesson Medical-Surgical Inc.
• 10.10. QIAGEN
• 10.11. SARSTEDT AG & Co. KG
• 10.12. AdvaCare Pharma